Myriad Ruling Vs. Biotech Patent Eligibility In Europe

After the U.S. Supreme Court's decision in Association for Molecular Pathology v. Myriad Genetics Inc., practitioners need to ensure that clients’ patent applications are drafted and prosecuted in a way that valuable claims are still obtained in the ...read more

  • Tags: